| SC 13G | 2023-12-22 | Lim Seah H. | Emmaus Life Sciences, Inc. | 4,586,626 | 7.4% | EDGAR |
| SC 13D/A | 2023-02-21 | Niihara Yutaka | Emmaus Life Sciences, Inc. | 20,979,966 | 35.9% | EDGAR |
| SC 13D/A | 2022-11-09 | Niihara Yutaka | Emmaus Life Sciences, Inc. | 13,431,166 | 26.4% | EDGAR |
| SC 13D/A | 2022-02-17 | Niihara Yutaka | Emmaus Life Sciences, Inc. | 13,748,040 | 26.6% | EDGAR |
| SC 13D/A | 2021-12-01 | Niihara Yutaka | Emmaus Life Sciences, Inc. | 13,605,090 | 26.3% | EDGAR |
| SC 13D/A | 2021-07-22 | Niihara Yutaka | Emmaus Life Sciences, Inc. | 13,358,405 | 25.8% | EDGAR |
| SC 13D/A | 2020-04-02 | Niihara Yutaka | Emmaus Life Sciences, Inc. | 13,122,477 | 25.7% | EDGAR |
| SC 13G/A | 2019-09-05 | JJBE 123 LLC | Emmaus Life Sciences, Inc. | 313,508 | 0.7% | EDGAR |
| SC 13G | 2019-08-26 | Telcon RF Pharmaceutical Inc. | Emmaus Life Sciences, Inc. | 4,147,491 | 8.7% | EDGAR |
| SC 13G/A | 2019-08-23 | GLASER JONATHAN M | Emmaus Life Sciences, Inc. | 1,406,430 | 3.0% | EDGAR |
| SC 13D | 2019-08-02 | Niihara Yutaka | Emmaus Life Sciences, Inc. | 12,779,707 | 25.6% | EDGAR |
| SC 13G | 2019-06-07 | JJBE 123 LLC | MYnd Analytics, Inc. | 694,123 | 5.5% | EDGAR |
| SC 13G | 2019-06-05 | Emerson John Steven | MYnd Analytics, Inc. | 694,121 | 5.5% | EDGAR |
| SC 13G | 2019-06-05 | GLASER JONATHAN M | MYnd Analytics, Inc. | 763,271 | 6.2% | EDGAR |
| SC 13D/A | 2018-11-30 | PAPPAJOHN JOHN | MYnd Analytics, Inc. | - | 18.9% | EDGAR |
| SC 13D | 2018-11-30 | Smith Robin L | MYnd Analytics, Inc. | - | 6.5% | EDGAR |
| SC 13G/A | 2018-10-01 | ritchie mark | MYnd Analytics, Inc. | 250,000 | 4.0% | EDGAR |
| SC 13G | 2018-07-11 | ritchie mark | MYnd Analytics, Inc. | 348,226 | 6.1% | EDGAR |
| SC 13D/A | 2016-11-03 | RSJ Investments SICAV a.s. | MYnd Analytics, Inc. | - | 25.9% | EDGAR |
| SC 13D/A | 2016-09-23 | RSJ Private Equity Investment Fund with variable registered capital, a.s. | MYnd Analytics, Inc. | - | 45.2% | EDGAR |